argenx SE | Investor Presentation Deck | 22 slides · page 22 of 22
The slide outlines a multi-stage clinical trial process including an open-label phase followed by a placebo-controlled relapse-based study.
Conference presentation · appendix_methodology · present_framework · balanced density
Slide locked Sign in to view
Slide schematic 3/3
diagram 1/1 list 1/1 title 1/1
Components 3
timeline bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1